METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES

Bibliografiske detaljer
Main Authors:	Kitley, J, Elsone, L, George, J, Jacob, A, Leite, M, Palace, J
Format:	Conference item
Udgivet:	2012

Lignende værker

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
af: Kitley, J, et al.
Udgivet: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
af: Kitley, J, et al.
Udgivet: (2013)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
af: Elsone, L, et al.
Udgivet: (2012)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
af: Kitley, J, et al.
Udgivet: (2013)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
af: Waters, P, et al.
Udgivet: (2015)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
af: Paul, F, et al.
Udgivet: (2007)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
af: Kitley, J, et al.
Udgivet: (2013)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
af: Waters, P, et al.
Udgivet: (2008)

Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
af: Elsone, L, et al.
Udgivet: (2014)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
af: Waters, P, et al.
Udgivet: (2016)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
af: Kitley, J, et al.
Udgivet: (2014)

Is azathioprine effective in highly-active neuromyelitis optica? A multicentre study from the United Kingdom
af: Elsone, L, et al.
Udgivet: (2013)

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
af: Palace, J, et al.
Udgivet: (2010)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
af: Kitley, J, et al.
Udgivet: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
af: Kitley, J, et al.
Udgivet: (2014)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
af: Leite, M, et al.
Udgivet: (2009)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
af: Jarius, S, et al.
Udgivet: (2008)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
af: Jarius, S, et al.
Udgivet: (2008)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
af: Kitley, J, et al.
Udgivet: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
af: Kitley, J, et al.
Udgivet: (2014)

Use of mitoxantrone in neuromyelitis optica.
af: Kitley, J, et al.
Udgivet: (2011)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
af: Kitley, J, et al.
Udgivet: (2012)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
af: Kitley, J, et al.
Udgivet: (2012)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
af: Nour, M, et al.
Udgivet: (2015)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
af: Jarius, S, et al.
Udgivet: (2008)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
af: Jarius, S, et al.
Udgivet: (2008)

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica
af: Wilson, R, et al.
Udgivet: (2018)

Risk factors for immunosuppression-associated infections in aquaporin-4 antibody mediated neuromyelitis optica spectrum disorders
af: Cheng, F, et al.
Udgivet: (2014)

Seasonal pattern of variation in neuromyelitis optica relapses
af: Elsone, L, et al.
Udgivet: (2012)

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
af: Akman-Demir, G, et al.
Udgivet: (2011)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
af: Kim, S, et al.
Udgivet: (2013)

Long term efficacy, adherence and reasons for discontinuation in 103 cases of neuromyelitis optica treated with azathioprine: a multicentre study from the United Kingdom
af: Elsone, L, et al.
Udgivet: (2013)

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
af: Pittock, S, et al.
Udgivet: (2019)

Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies
af: Cavus, F, et al.
Udgivet: (2013)

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
af: Waters, P, et al.
Udgivet: (2008)

Distinction of aquaporin-4 antibody positive neuromyelitis optica from multiple sclerosis using diffusion tensor and myelin water imaging
af: Matthews, L, et al.
Udgivet: (2011)

Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
af: Min, J, et al.
Udgivet: (2010)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
af: Kitley, J, et al.
Udgivet: (2012)

A practical guide to the treatment of neuromyelitis optica.
af: Palace, J, et al.
Udgivet: (2012)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
af: Collongues, N, et al.
Udgivet: (2013)